Angerer, K. Frog tales – on poison dart frogs, epibatidine, and the sharing of biodiversity, Innovation. The European Journal of Social Science Research, 2011, 24:3, 353-369

Daly, J. W., Garraffo, H. M., Spande, T. F., Decker, M. W., Sullivan, J. P., Williams, M. (2000). Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics. Natural Product Report. 17(2):131-5.

Darst, C. R., Menéndez‐Guerrero, P. A., Coloma, L. A., Cannatella, D. C. (2005). Evolution of Dietary Specialization and Chemical Defense in Poison Frogs (Dendrobatidae): A Comparative Analysis. The American Naturalist, Vol. 165, No. 1, pp. 56-69.

Gillis, A.M. (2002). Serendipity and sweat in science. ‘‘Frog Man’’ Daly follows curiosity to ends of the Earth. The NIH record, 44(18). Available from: http://nihrecord.od.nih.gov/newsletters/09_03_2002/story01.htm [Accessed 2 October 2017].

Lötters, S., Miyata, K. y Proy, C. (2003). Another new riparian dendrobatid frog species from the upper Amazon basin of Peru. Journal of Herpetology 37:707-713.

Tarvin, R. D., Borghese C. M., Sachs, W., Harris R. A., Santos J. C., Zakon, H. H., Lu, Y., O'Connell, L. A., Cannatella, D. C. (2017). Interacting amino acid replacements allow poison frogs to evolve epibatidine resistance. Science 357 (6357), 1261-1266.

Spande, T.F., Garraffo, H. M., Edwards, M. W., Yeh, H. J. C., Panne, L., Daly, J. W. (1992). Epibatidine: A Novel (Chloropyridy1) azabicycloheptane with Potent Analgesic Activity from an Ecuadoran Poison Frog.  Journal of the American Chemical Society. 114, 3415-3418.

Scroll Up